VIR BIOTECHNOLOGY, I

VIR
Delayed Quote. Delayed  - 05/13 04:00:00 pm
39.55USD +1.13%

Turn to zoom
Prev.39.1100
Open39.4600
High41.1100
Low38.3050
Volume416 235
Latest news
3d ago
3d ago
6d ago
6d ago
Chart VIR BIOTECHNOLOGY, INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishNeutralNeutral
Resistance45,083,176,6
Spread/Res.-12%-52%-48%
Spread/Supp.2,1%50%48%
Support38,826,326,8
Financials
Sales 2021 375 M - -
Net income 2021 -274 M - -
Net cash 2021 364 M - -
P/E ratio 2021 -18,3x
Yield 2021 -
Capitalization 5 143 M 5 143 M -
EV / Sales 2021 12,7x
EV / Sales 2022 7,31x
Nbr of Employees 340
Free-Float 84,1%
Company
Vir Biotechnology, Inc. is a clinical-stage immunology company. The Company is focused on developing treatments to treat and prevent serious infectious diseases. Its technology platforms are focused on antibodies, T cells, innate immunity and small interfering ribonucleic acid (siRNA). Its pipeline...

>> Read more
Sector :
Other Biotechnology & Medical Research
Calendar :
2021-05-20 Shareholder meeting
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 79,17 $
Last Close Price 39,55 $
Spread / Highest target 241%
Spread / Average Target 100%
Spread / Lowest Target -16,6%